Fund

Langmafeng Venture Capital

朗玛峰创投

Langmafeng Venture Capital is a Chinese venture capital firm that has led or participated in several technology and healthcare deals in recent years. Per BlueRun Ventures coverage, it led the pre-A round of over 100 million RMB for Fabarta in April 2023 , led the A1 round for Yanhuang Data in late 2022 , and followed on in Xiruan Technology's Series B alongside Sequoia China and Gaorong Capital in early 2022 . elsewhere's corpus does not contain details on its founding date, fund size, or overall strategy.

AI-generated — may contain errors, please verify.

Langmafeng Venture CapitalFund
朗玛峰创投
渲染中…
Mentioned in 9 articles

Coverage